Nu-Med Plus (NUMD) Depreciation & Amortization (CF) (2012 - 2022)

Nu-Med Plus has disclosed Depreciation & Amortization (CF) across 11 years of filings, most recently posting $35.0 for Q3 2022.

• Depreciation & Amortization (CF) for Q3 2022 came in at $35.0, down 98.68% year-over-year; the trailing twelve-month figure through Jun 2023 was $35.0 (down 99.54% YoY), and the FY2022 annual result was $2267.0, down 75.79% from the prior year.
• Depreciation & Amortization (CF) came in at $35.0 for Q3 2022 at Nu-Med Plus, down from $217.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $3803.0 in Q2 2018 to a low of $35.0 in Q3 2022.
• The 5-year median for Depreciation & Amortization (CF) is $3048.0 (2020), against an average of $2712.4.
• Across the five-year window, Depreciation & Amortization (CF) surged 100.62% in 2018 and slumped 98.68% in 2022, its largest moves.
• Nu-Med Plus' Depreciation & Amortization (CF) stood at $3774.0 in 2018, then retreated by 19.55% to $3036.0 in 2019, then decreased by 12.71% to $2650.0 in 2020, then changed by 0.0% to $2650.0 in 2021, then plunged by 98.68% to $35.0 in 2022.
• The last three Depreciation & Amortization (CF) figures came in at $35.0 (Q3 2022), $217.0 (Q2 2022), and $2015.0 (Q1 2022), per Business Quant data.